Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment.

Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment. Stroke. 2020 09; 51(9):2697-2704.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Angiography
Arterial Occlusive Diseases
Cerebral Infarction
Embolization, Therapeutic
Endovascular Procedures
Female
Fibrinolytic Agents
Humans
Male
Middle Aged
Prospective Studies
Risk Assessment
Stroke
Tissue Plasminogen Activator
Tomography, X-Ray Computed
Treatment Outcome

authors with profiles

Mai Nhu Nguyen-Huynh, MD, MAS
Andrew L. Avins, MD, MPH